MEDP

Medpace Holdings Inc

MEDP, USA

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

https://www.medpace.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
MEDP
stock
MEDP

Evaluating Medpace (MEDP) After Strong Growth, Investor Support, and Aggressive Buybacks Fuel a Rerating simplywall.st

Read more →
MEDP
stock
MEDP

Medpace Holdings, Inc. $MEDP is Bares Capital Management Inc.'s 8th Largest Position MarketBeat

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

HOLD

Target Price:

$538.25

Analyst Picks

Strong Buy

2

Buy

0

Hold

10

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

Low

41.18

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very High

56.69

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very High

37.85 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Medium

6.34 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very High

34.87 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

4.97

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 71.63% of the total shares of Medpace Holdings Inc

1.

BlackRock Inc

(8.7733%)

since

2025/06/30

2.

Vanguard Group Inc

(8.5097%)

since

2025/06/30

3.

Wasatch Advisors LP

(3.3667%)

since

2025/06/30

4.

Mawer Investment Management Ltd

(2.9097%)

since

2025/06/30

5.

iShares Core S&P Mid-Cap ETF

(2.7308%)

since

2025/08/31

6.

Vanguard Total Stock Mkt Idx Inv

(2.5726%)

since

2025/07/31

7.

State Street Corp

(2.5158%)

since

2025/06/30

8.

Renaissance Technologies Corp

(2.4137%)

since

2025/06/30

9.

Geode Capital Management, LLC

(2.2708%)

since

2025/06/30

10.

AQR Capital Management LLC

(2.2112%)

since

2025/06/30

11.

Vanguard Small Cap Index

(1.9871%)

since

2025/07/31

12.

Baillie Gifford & Co Limited.

(1.8592%)

since

2025/06/30

13.

Bessemer Group Inc

(1.8071%)

since

2025/06/30

14.

Morgan Stanley - Brokerage Accounts

(1.7379%)

since

2025/06/30

15.

TD Asset Management Inc

(1.629%)

since

2025/06/30

16.

Invesco World Dev Countries Eq Mother

(1.6235%)

since

2025/01/23

17.

Amvescap Plc.

(1.6085%)

since

2025/06/30

19.

Riverbridge Partners LLC

(1.545%)

since

2025/06/30

20.

Dimensional Fund Advisors, Inc.

(1.4742%)

since

2025/06/30

21.

Millennium Management LLC

(1.2278%)

since

2025/06/30

22.

D. E. Shaw & Co LP

(1.2229%)

since

2025/06/30

23.

Invesco S&P MidCap Quality ETF

(1.2104%)

since

2025/08/29

24.

Northern Trust Corp

(1.1984%)

since

2025/06/30

25.

Vanguard Small Cap Growth Index Inv

(1.119%)

since

2025/07/31

26.

Jane Street Group LLC

(1.1098%)

since

2025/06/30

27.

Findlay Park American I USD Dist

(1.0949%)

since

2025/06/30

28.

Vanguard Explorer Inv

(0.971%)

since

2025/06/30

29.

Vanguard Institutional Extnd Mkt Idx Tr

(0.9014%)

since

2025/07/31

30.

Wasatch Core Growth

(0.7847%)

since

2025/06/30

31.

Mawer Global Equity A

(0.6486%)

since

2025/07/31

32.

SPDR® S&P MIDCAP 400 ETF Trust

(0.6426%)

since

2025/07/31

33.

TD Epoch Glb Qlty Capital Reinvestment

(0.6263%)

since

2025/06/30

34.

TD Global Capital Reinvestment - I

(0.6223%)

since

2024/12/31

35.

Madison Mid Cap Y

(0.549%)

since

2025/07/31

36.

iShares Russell Mid-Cap Growth ETF

(0.5357%)

since

2025/08/31

37.

Wasatch Small Cap Growth Investor

(0.5177%)

since

2025/06/30

38.

Manulife Global Equity Class F

(0.5114%)

since

2025/07/31

39.

TD U.S. Capital Reinvestment I

(0.511%)

since

2024/12/31

40.

iShares Biotechnology ETF

(0.4951%)

since

2025/08/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

4.18

Latest Release

Date

2025-09-30

EPS Actual

3.86

EPS Estimate

3.53

EPS Difference

0.33

Surprise Percent

9.3484%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(3)
Economic Moat
Wide Moat Company(9)
GARP
Fair GARP(6)
Growth
High Growth(6.5)
Momentum
Moderate Momentum(4.5)
Net Net
Possible Net-Net(4)
Quality
High Quality(8.5)
Value
Fair Value(5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.